These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23689213)

  • 1. Advancing the science of pharmacovigilance.
    Honig PK
    Clin Pharmacol Ther; 2013 Jun; 93(6):474-5. PubMed ID: 23689213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the evidence consistency of pharmacovigilance outcomes between Food and Drug Administration Adverse Event Reporting System and electronic medical record data for acute mania patients.
    Duan R; Zhang X; Du J; Huang J; Tao C; Chen Y
    Health Informatics J; 2020 Jun; 26(2):753-764. PubMed ID: 30887861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Logistic regression in signal detection: another piece added to the puzzle.
    Caster O; Norén GN; Madigan D; Bate A
    Clin Pharmacol Ther; 2013 Sep; 94(3):312. PubMed ID: 23695184
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to "Logistic regression in signal detection: another piece added to the puzzle".
    Harpaz R; DuMouchel W; LePendu P; Bauer-Mehren A; Ryan P; Shah NH
    Clin Pharmacol Ther; 2013 Sep; 94(3):313. PubMed ID: 23756371
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.
    Hartford CG; Petchel KS; Mickail H; Perez-Gutthann S; McHale M; Grana JM; Marquez P
    Drug Saf; 2006; 29(8):657-73. PubMed ID: 16872240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?
    Coloma PM; Trifirò G; Patadia V; Sturkenboom M
    Drug Saf; 2013 Mar; 36(3):183-97. PubMed ID: 23377696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.
    Almenoff JS; LaCroix KK; Yuen NA; Fram D; DuMouchel W
    Drug Saf; 2006; 29(10):875-87. PubMed ID: 16970511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.
    Harpaz R; DuMouchel W; LePendu P; Bauer-Mehren A; Ryan P; Shah NH
    Clin Pharmacol Ther; 2013 Jun; 93(6):539-46. PubMed ID: 23571771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
    Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
    Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.
    Maro JC; Brown JS; Dal Pan GJ; Kulldorff M
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):839-48. PubMed ID: 24700557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records.
    Lee S; Choi J; Kim HS; Kim GJ; Lee KH; Park CH; Han J; Yoon D; Park MY; Park RW; Kang HR; Kim JH
    J Am Med Inform Assoc; 2017 Jul; 24(4):697-708. PubMed ID: 28087585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of Spontaneously Reported Adverse Events].
    Nakamura M
    Yakugaku Zasshi; 2016; 136(4):549-56. PubMed ID: 27040337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the centers for education and research on therapeutics (CERTs) in pharmacovigilance and proper use of therapeutics.
    Tilson HH; Madre LK; Califf RM
    Clin Pharmacol Ther; 2007 Aug; 82(2):118-21. PubMed ID: 17632533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian hierarchical modeling for detecting safety signals in clinical trials.
    Xia HA; Ma H; Carlin BP
    J Biopharm Stat; 2011 Sep; 21(5):1006-29. PubMed ID: 21830928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database.
    Florek AG; Nardone B; Thareja S; Tran G; Giles FJ; West DP
    Br J Dermatol; 2017 Nov; 177(5):e220-e221. PubMed ID: 28646575
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm.
    Yoon D; Park MY; Choi NK; Park BJ; Kim JH; Park RW
    Clin Pharmacol Ther; 2012 Mar; 91(3):467-74. PubMed ID: 22237257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources.
    Trifirò G; Sultana J; Bate A
    Drug Saf; 2018 Feb; 41(2):143-149. PubMed ID: 28840504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.
    Awada Z; Zgheib NK
    Pharmacogenomics; 2014 Apr; 15(6):845-56. PubMed ID: 24897290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.